1. Home
  2. NGL vs CGEM Comparison

NGL vs CGEM Comparison

Compare NGL & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGL
  • CGEM
  • Stock Information
  • Founded
  • NGL 1940
  • CGEM 2016
  • Country
  • NGL United States
  • CGEM United States
  • Employees
  • NGL N/A
  • CGEM N/A
  • Industry
  • NGL Natural Gas Distribution
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • NGL Utilities
  • CGEM Health Care
  • Exchange
  • NGL Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • NGL 626.5M
  • CGEM 482.7M
  • IPO Year
  • NGL 2011
  • CGEM 2021
  • Fundamental
  • Price
  • NGL $5.41
  • CGEM $7.54
  • Analyst Decision
  • NGL
  • CGEM Strong Buy
  • Analyst Count
  • NGL 0
  • CGEM 7
  • Target Price
  • NGL N/A
  • CGEM $26.57
  • AVG Volume (30 Days)
  • NGL 869.5K
  • CGEM 361.9K
  • Earning Date
  • NGL 08-07-2025
  • CGEM 08-07-2025
  • Dividend Yield
  • NGL N/A
  • CGEM N/A
  • EPS Growth
  • NGL N/A
  • CGEM N/A
  • EPS
  • NGL N/A
  • CGEM N/A
  • Revenue
  • NGL $3,332,108,000.00
  • CGEM N/A
  • Revenue This Year
  • NGL N/A
  • CGEM N/A
  • Revenue Next Year
  • NGL N/A
  • CGEM N/A
  • P/E Ratio
  • NGL N/A
  • CGEM N/A
  • Revenue Growth
  • NGL 1.08
  • CGEM N/A
  • 52 Week Low
  • NGL $2.64
  • CGEM $6.85
  • 52 Week High
  • NGL $5.73
  • CGEM $19.89
  • Technical
  • Relative Strength Index (RSI)
  • NGL 75.19
  • CGEM 47.12
  • Support Level
  • NGL $5.01
  • CGEM $7.50
  • Resistance Level
  • NGL $5.50
  • CGEM $8.11
  • Average True Range (ATR)
  • NGL 0.19
  • CGEM 0.38
  • MACD
  • NGL 0.05
  • CGEM 0.01
  • Stochastic Oscillator
  • NGL 89.20
  • CGEM 36.59

About NGL NGL ENERGY PARTNERS LP Common Units representing Limited Partner Interests

NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: